Liraglutide Alleviates Cognitive Deficit in db/db Mice: Involvement in Oxidative Stress, Iron Overload, and Ferroptosis

• Published in: Neurochemical research Vol. 47; no. 2; pp. 279 - 294
• Main Authors: An, Ji-Ren, Su, Jia-Nan, Sun, Gui-Yan, Wang, Qing-Feng, Fan, Ya-Dong, Jiang, Nan, Yang, Yu-Feng, Shi, Yan
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.02.2022; Springer Nature B.V
• Subjects: Animals; Antidiabetics; Biochemistry; Biomedical and Life Sciences; Biomedicine; Brain-derived neurotrophic factor; Cell Biology; Cognition; Cognitive ability; Cognitive Dysfunction - drug therapy; Damage; Diabetes; Diabetes mellitus; Ferroptosis; Hippocampal plasticity; Hippocampus; Impairment; Iron; Iron Overload - drug therapy; Lipid metabolism; Lipid peroxidation; Lipids; Liraglutide - pharmacology; Liraglutide - therapeutic use; Mice; Mice, Inbred Strains; Mitochondria; Neurochemistry; Neurodegenerative diseases; Neurology; Neurons; Neurosciences; Original Paper; Overloading; Oxidative stress; Oxidative Stress - physiology; Peroxidation; Proteins; Superoxide dismutase; Synapses; Synaptic plasticity; Iron overload; Oxidative stress; Ferroptosis; Diabetic cognitive impairment; Liraglutide
• ISSN: 0364-3190; 1573-6903
• DOI: 10.1007/s11064-021-03442-7

Studies have shown that diabetes is associated with the occurrence of neurodegenerative diseases and cognitive decline. However, there is currently no effective treatment for diabetes-induced cognitive dysfunction. The superior efficacy of liraglutide (LIRA) for cognitive impairment and numerous neurodegenerative diseases has been widely demonstrated. This study determined the effects of LIRA on diabetic cognitive impairment and on the levels of oxidative stress, lipid peroxidation, iron metabolism and ferroptosis in the hippocampus. Mice were injected daily with liraglutide (200 μg/kg/d) for 5 weeks. LIRA could repair damaged neurons and synapses, and it increased the protein expression levels of PSD 95, SYN, and BDNF. Furthermore, LIRA significantly decreased oxidative stress and lipid peroxidation levels by downregulating the production of ROS and MDA and upregulating SOD and GSH-Px in the serum and hippocampus, and the upregulation of SOD2 expression was also proven. The decreased levels of TfR1 and the upregulation of FPN1 and FTH proteins observed in the LIRA-treated db/db group were shown to reduce iron overload in the hippocampus, whereas the increased expression of Mtft and decreased expression of Mfrn in the mitochondria indicated that mitochondrial iron overload was ameliorated. Finally, LIRA was shown to prevent ferroptosis in the hippocampus by elevating the expression of GPX4 and SLC7A11 and suppressing the excessive amount of ACSL4; simultaneously, the damage to the mitochondria observed by TEM was also repaired. For the first time, we proved in the T2DM model that ferroptosis occurs in the hippocampus, which may play a role in diabetic cognitive impairment. LIRA can reduce oxidative stress, lipid peroxidation and iron overload in diabetic cognitive disorders and further inhibit ferroptosis, thereby weakening the damage to hippocampal neurons and synaptic plasticity and ultimately restoring cognitive function.